Advancing Non-Cell Therapy Innovations to Combat Autoimmune & Inflammatory Diseases

• Highlighting apoptosis driven immune tolerance key signaling pathways
• Discussing supporting preclinical and mechanistic studies that inform trial design
• Reviewing clinical trial data in celiac disease and primary biliary cholangit

Speakers:

Joseph Podojil

Director of Immunlogy

COUR Pharmaceuticals